Oramed Pharmaceuticals (ORMP -0.7%) says it's been in talks with the FDA regarding its...
Oramed Pharmaceuticals (ORMP -0.7%) says it's been in talks with the FDA regarding its Investigational New Drug application for oral insulin. The FDA has asked Oramed to perform a sub study in a controlled in-patient setting for up to a one-week period. Oramed will submit a new IND with a clinical protocol for the study.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs